The European market is subject to changes. The expected Brexit brings along changes and uncertainties. New laws and regulations (MDR/ IVDR) impose new requirements for new but also already marketed products. An increasing demand for clinical data before and during registration processes will result in more activities in that field. At Lacidem we understand the needs for being succesful in European life science markets and also the similarities and the differences between medical devices and pharmaceuticals.
We team-up with our customers, create realistic expectations and ensure transparency at all times. Our customers range from start-ups to established companies. New companies lacking medical or clinical capacity and expertise or established companies with (temporarily) limited medical staff but requiring clinical or medical "maintenance" activities.